Search results
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 13 hours agoIts next-gen CF therapy also aced a late-stage study, and it advanced inaxaplin, an investigational treatment for APOL-1 mediated kidney disease, to the...
Ozempic maker sets clinical trial to study drug's effect on alcohol consumption
Scripps News via AOL· 5 days agoAnd while Danish drugmaker Novo Nordisk has acknowledged that possibility, it's not precisely the...
Certain menopausal hormone therapy could raise ovarian cancer risk, study finds
BioPharma Dive via Yahoo Finance· 2 days ago“Our study provides the only long-term information from a randomized clinical trial on two common...
Cancer Clinical Trial Participation May Not Actually Improve Survival, Study Says
MedPage Today· 4 days agoCancer clinical trial participation was not associated with longer survival after accounting for...
Study finds good clinical outcomes for over 30% of ischemic stroke patients receiving endovascular...
Medical Xpress· 5 days agoThe study, conducted over five years, found that over 30% of patients who received endovascular treatment had a good clinical outcome even after six hours ...
Does Medicare Part D cover prescriptions for clinical trials? | Chattanooga Times Free Press
Chattanooga Times Free Press· 10 hours agoAre clinical trial prescriptions covered under Medicare's drug plans? What a smart decision you made...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 3 days agoAccording to a federal registry of clinical trials, the trial should be completed in July. The...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing ...
WPRI Providence· 17 hours agoNovartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical< ...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further...
FOX 59 Indianapolis· 16 hours agoIn the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS)...
Study finds many GLP-1 weight-loss patients discontinue treatment too soon
theGrio· 3 days agoPatients begin with a low dose of the medications and are supposed to gradually increase it over...